SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (214)4/22/2006 11:52:09 AM
From: Mike McFarland  Read Replies (1) | Respond to of 360
 
Okay okay, after yesterday GLGC has underperformed.

<Losses increased to $11.8 million, or 37 cents per share,
from a loss of $4.1 million, or 13 cents per share, in the year-ago period.>

The shares sold off 26%--losing more than a buck a share
to close at $3.10



To: Mike McFarland who wrote (214)6/11/2006 2:20:31 PM
From: Mike McFarland  Read Replies (1) | Respond to of 360
 
I periodically like look in the rear view mirror--
updating that chart:

finance.yahoo.com

Not bad, I haven't lost any money in the past six months
(the one year chart show Solexa leading, others trailing).

You can lose your mind looking at comparison charts:
finance.yahoo.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News